← All trials
NCT06822049
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 10, 2025
- Primary completion
- Jul 31, 2026
- Completion date
- Feb 28, 2027
- First posted
- Feb 12, 2025
- Last posted
- Oct 8, 2025
- Enrollment
- 200
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- State University of New York, BuffaloLead sponsor
- University of Alabama, BirminghamCollaborator
- State University of New York, BuffaloSponsor investigator
- Medical University of South CarolinaCollaborator
- National Center for Advancing Translational Science (NCATS)Collaborator
- University of PennsylvaniaCollaborator
- University of PennsylvaniaCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.